These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7553646)

  • 61. Loss of heterozygosity on chromosome 14 in neuroblastoma.
    Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
    Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
    [No Abstract]   [Full Text] [Related]  

  • 62. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
    Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
    Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Neuroblastoma; biology and prognostic factors].
    Shimada H; Aotama C; Newton WA
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):44-9. PubMed ID: 3800408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.
    Takeda O; Homma C; Maseki N; Sakurai M; Kanda N; Schwab M; Nakamura Y; Kaneko Y
    Genes Chromosomes Cancer; 1994 May; 10(1):30-9. PubMed ID: 7519871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
    Fong CT; Dracopoli NC; White PS; Merrill PT; Griffith RC; Housman DE; Brodeur GM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3753-7. PubMed ID: 2566996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
    Noguera R; Cañete A; Pellín A; Ruiz A; Tasso M; Navarro S; Castel V; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jan; 140(2):157-61. PubMed ID: 12645655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
    Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.
    Van Roy N; Jauch A; Van Gele M; Laureys G; Versteeg R; De Paepe A; Cremer T; Speleman F
    Cancer Genet Cytogenet; 1997 Sep; 97(2):135-42. PubMed ID: 9283597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
    Maris JM; Weiss MJ; Guo C; Gerbing RB; Stram DO; White PS; Hogarty MD; Sulman EP; Thompson PM; Lukens JN; Matthay KK; Seeger RC; Brodeur GM
    J Clin Oncol; 2000 May; 18(9):1888-99. PubMed ID: 10784629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma.
    Christiansen H; Sahin K; Berthold F; Hero B; Terpe HJ; Lampert F
    Eur J Cancer; 1995; 31A(4):541-4. PubMed ID: 7576963
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
    Caron H; Spieker N; Godfried M; Veenstra M; van Sluis P; de Kraker J; Voûte P; Versteeg R
    Genes Chromosomes Cancer; 2001 Feb; 30(2):168-74. PubMed ID: 11135433
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New genetic loci in neuroblastoma.
    Schwab M; Corvi R; Savelyeva L
    Klin Padiatr; 1997; 209(4):147-9. PubMed ID: 9293445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.
    Brodeur GM; Fong CT; Morita M; Griffith R; Hayes FA; Seeger RC
    Prog Clin Biol Res; 1988; 271():3-15. PubMed ID: 3043452
    [No Abstract]   [Full Text] [Related]  

  • 78. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
    Komuro H; Valentine MB; Rowe ST; Kidd VJ; Makino S; Brodeur GM; Cohn SL; Look AT
    J Pediatr Surg; 1998 Nov; 33(11):1695-8. PubMed ID: 9856898
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deletion mapping of chromosome 1p and 22q in pheochromocytoma.
    Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
    Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG
    Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.